These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37810604)

  • 41. Clinical characteristics and health outcomes in patients with alcohol withdrawal syndrome: an observational study from Oman.
    Al-Maqbali JS; Al-Maqrashi N; Al-Huraizi A; Al-Mamari QS; Al Alawa K; Al Alawi AM
    Ann Saudi Med; 2022; 42(1):52-57. PubMed ID: 35112593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baclofen for alcohol withdrawal.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Assessment and Treatment of Alcohol Withdrawal Syndrome].
    Choi HY; Seo JS; Lee SK
    Korean J Gastroenterol; 2020 Aug; 76(2):71-77. PubMed ID: 32839369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenobarbital and Alcohol Withdrawal Syndrome: A Systematic Review and Meta-Analysis.
    Umar Z; Haseeb Ul Rasool M; Muhammad S; Yousaf S; Nassar M; Ilyas U; Hosna AU; Parikh A; Bhangal R; Ahmed N; Ariyaratnam J; Trandafirescu T
    Cureus; 2023 Jan; 15(1):e33695. PubMed ID: 36788902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of an ICU-Specific Alcohol Withdrawal Syndrome Management Protocol Reduces the Need for Mechanical Ventilation.
    Heavner JJ; Akgün KM; Heavner MS; Eng CC; Drew M; Jackson P; Pritchard D; Honiden S
    Pharmacotherapy; 2018 Jul; 38(7):701-713. PubMed ID: 29800507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence, Predictors, and Prognosis of Alcohol Withdrawal Syndrome and Delirium Tremens Following Traumatic Injury.
    Salottolo K; McGuire E; Mains CW; van Doorn EC; Bar-Or D
    Crit Care Med; 2017 May; 45(5):867-874. PubMed ID: 28266937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.
    Vigouroux A; Garret C; Lascarrou JB; Martin M; Miailhe AF; Lemarié J; Dupeyrat J; Zambon O; Seguin A; Reignier J; Canet E
    PLoS One; 2021; 16(12):e0261443. PubMed ID: 34928984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of alcohol withdrawal syndrome severity on sleep, brain and cognition.
    Laniepce A; Cabé N; André C; Bertran F; Boudehent C; Lahbairi N; Maillard A; Mary A; Segobin S; Vabret F; Rauchs G; Pitel AL
    Brain Commun; 2020; 2(2):fcaa123. PubMed ID: 33543128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
    Barrons R; Roberts N
    J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of alcohol use and withdrawal on trauma outcomes: A case control study.
    Ng C; Fleury M; Hakmi H; Bronson B; Vosswinkel JA; Huang EC; Shapiro M; Jawa RS
    Am J Surg; 2021 Aug; 222(2):438-445. PubMed ID: 33454025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital.
    Monte R; Rabuñal R; Casariego E; López-Agreda H; Mateos A; Pértega S
    Alcohol Alcohol; 2010; 45(2):151-8. PubMed ID: 20075027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.
    Smith JT; Sage M; Szeto H; Myers LC; Lu Y; Martinez A; Kipnis P; Liu VX
    JAMA Netw Open; 2022 Feb; 5(2):e220158. PubMed ID: 35191968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges.
    Farrokh S; Roels C; Owusu KA; Nelson SE; Cook AM
    Neurocrit Care; 2021 Apr; 34(2):593-607. PubMed ID: 32794143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.
    Wong A; Benedict NJ; Armahizer MJ; Kane-Gill SL
    Ann Pharmacother; 2015 Jan; 49(1):14-9. PubMed ID: 25325907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management.
    Duby JJ; Berry AJ; Ghayyem P; Wilson MD; Cocanour CS
    J Trauma Acute Care Surg; 2014 Dec; 77(6):938-43. PubMed ID: 25248063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.